SCHEDULE
2024
: This symbol displays the video in full screen mode and this one returns to the initial size.
Dr. William McBride
Proteasome in radiation responses and radiovaccination
Dr. Florian Greten
Targeting cancer-associated fibroblasts in rectal cancer
Dr. Mary Helen Barcellos-Hoff
Capitalizing on TGFb's complexity in cancer
Dr. Luigi Marchionni
A hitchhikers guide to bid data based biomarkers - Lessons learned over two decades
Dr. Jason Luke
Exploring the aDscopal intersection of SBRT and immune checkpoint blockade
Dr. Marie Catherine Vozenin
Pre-clinical studies with FLASH – What do we know?
Dr. Aditya Juloori
Radiation/Immunotherapy Clinical Trials: What do we know (so far)?
Dr. Tian Liu
Minimizing radiation side effects: Ultrasound strategies for predicting and monitoring normal tissue toxicities in cancer radiotherapy
Dr. Scott Bratman
Utility of circulating tumor DNA in radiation oncology
Dr. Jamie Honeychurch
Overview of Innate and adaptive immunity: A foundation for tumor immunology
Dr. Famke Schneiders
Radio-immunotherapy combinations and effect of RT on lymph nodes
Dr. Ibrahim Hatipoglu
Fundamentals of tumor immunology
Dr. Kevin Harrington
Enhancing the effects of tumour irradiation through microenvironmental conditioning and optimized adjuvant therapy
Dr. Jonathan Schoenfeld
Immunotherapy and radiation: a clinical/translational perspective
Dr. Keyur Shah
From data to decisions: the role of radation sciences in radiation oncology
2.15.1.0